[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367630-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367630-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","sensitivity-to-an-inhibitor-of-translation-elongation-in-solid-and-hematologic-cancers","Sensitivity to an Inhibitor of Translation Elongation in Solid and Hematologic Cancers","","Protein synthesis inhibitors are promising anticancer agents because many oncogenic driver proteins are inherently unstable; blocking synthesis can deplete these proteins. Prior work identified SVC112, a small-molecule inhibitor of translation elongation that targets head and neck cancer stem cells and suppresses xenograft regrowth after radiation. Here, SVC112 shows inhibitor activity without radiation and exhibits a 1600-fold growth-inhibitory range across diverse cancer cell lines. Molecular correlates link baseline apoptosis/survival factor expression to SVC112-induced apoptosis in hematologic lines, while c-Myc phosphorylation correlates with sensitivity in colorectal lines. Apoptosis induction predicts tumor control and survival benefit in mouse xenograft models, supporting a framework based on cancer-cell dependence on survival factors and on post-translational stability of oncogenic drivers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sensitivity-to-an-inhibitor-of-translation-elongation-in-solid-and-hematologic-cancers/367630/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sensitivity-to-an-inhibitor-of-translation-elongation-in-solid-and-hematologic-cancers/367630.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is SVC112 and what does it target in translation?","Question",{"text":63,"@type":64},"SVC112 is a small-molecule inhibitor of translation elongation. It disrupts elongation processes and leads to cancer-cell growth inhibition.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SVC112 act beyond radiation treatment?",{"text":68,"@type":64},"SVC112 shows activity on its own without radiation. It suppresses growth across cancer cell lines with a large (1600-fold) range in sensitivity.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular signals correlate with SVC112 sensitivity in different cancers?",{"text":72,"@type":64},"In hematologic cancer cell lines, basal apoptosis/survival factor expression correlates with SVC112-induced apoptosis. In colorectal cancer cell lines, phosphorylation of c-Myc correlates with sensitivity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367630,1791109824,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSensitivity to an inhibitor of translation elongation in solid and hematologic cancers  \nNathan Gomes1,2, Barbara Frederick1,2, John Tentler3,4 & TinTin Su1,2,4􀀍  \nInhibitors of protein synthesis hold promise for cancer therapy because many cancer driver proteins are unstable and blocking synthesis leads to their depletion. We described previously SVC112, a small molecule inhibitor of translation elongation that inactivates Head and Neck Squamous Cell Carcinoma (HNSCC) stem cells in vitro and prevents the regrowth of HNSCC tumor xenografts in mice after radiation treatment. Here we report that SVC112 also shows activity on its own (without radiation) but with a 1600-fold range in growth inhibition among cancer cell lines of various origins. Our efforts to define molecular correlates of SVC112 sensitivity found that basal expression of apoptosis/ survival factors correlates with SVC112-induced apoptosis in hematologic cancer cell lines, while phosphorylation of c-Myc correlates with sensitivity to SVC112 in colorectal cancer cell lines. Apoptosis induction by SVC112 predicts tumor growth control and survival benefit in mouse xenograft models. We suggest a paradigm wherein utility of translation inhibitors is defined by (1) inherent dependence of cancer cells on specific survival factors and (2) post-translational modifications that affect the stability of oncogenic driver proteins.  \nKeywords Protein synthesis, Translation, Elongation factor 2, AML, Myeloma, Colorectal cancer  \nGrowth, proliferation and survival of cancer cells rely upon the continuous presence of unstable cancer driver proteins such as c-Myc, Cyclin D1 and MCL-1 . Consequently, protein synthesis inhibitors have long been hypothesized to have therapeutic potential in cancer as blocked synthesis would lead to the depletion of unstable cancer driver proteins according to their intrinsic instability.  \nTranslation initiates on most transcripts via mechanisms that rely on the 7-methylguanosine (m7G) cap (cap-dependent initiation), while some transcripts harbor Internal Ribosome Entry Sequences (IRES) and can initiate also in a cap-independent manner (reviewed in1,2). Regardless of the initiation mechanism, all transcripts undergo translation elongation to produce polypeptides. The elongation cycle, which must be completed for sequential amino acid addition to the peptide chain, includes the cyclic association/dissociation of eukaryotic Elongation Factors 1 and 2 (eEF1/EF1 and eEF2/EF2) from the ribosome. EF1 brings the tRNA-amino acid (aa) complex to the acceptor (A) site of the ribosome, whereas EF2 helps translocate the tRNA-nascent peptide complex, and then vacating the A site for the next tRNA-aa complex. EF1 and EF2 associate with the ribosome in GTP-bound states and dissociate in GDP-bound states to allow for the next elongation cycle. The elongation phase of translation can be dynamically regulated. For example, EF2 kinase (EF2K) phosphorylates and inhibits EF2 to pause translation after DNA damage, but for successful cellular recovery, EF2K must then be degraded and EF2 re-activated in human osteosarcoma cells3. EF2K is also important for cancer cell survival during nutritional and metabolic stress, and its overexpression correlates with poor prognosis4,5.  \nCap-dependent initiation is dysregulated in many cancers, and several initiation factors are targets of oncology therapeutic development (reviewed in6). However, during stress, hypoxia and other conditions relevant to the tumor microenvironment, cap-dependent translation can be significantly inhibited, and cells rely upon cap-independent, IRES-driven translation7–9. Among the ~ 35% of human mRNAs containing putative IRES sequences10 are transcripts encoding cancer-relevant proteins with validated IRES’s, such as Myc and cyclin D1  \n11, 12. Consequently, IRES-driven initiation can render translation refractory to pharmacologi","cbCaikvZbfIupm24","https://ap.wps.com/l/cbCaikvZbfIupm24","pdf",5329726,13,"English","# Background and rationale\n## Unstable driver proteins and translation inhibition\n## Translation initiation and elongation mechanisms\n# SVC112 activity and sensitivity range\n## Radiation-independent growth inhibition\n## Variability across cancer cell lines\n# Molecular correlates of SVC112 sensitivity\n## Apoptosis/survival factors in hematologic lines\n## c-Myc phosphorylation in colorectal lines\n# Therapeutic implications and predictive outcomes\n## Apoptosis induction and xenograft survival benefit\n## Paradigm for translation inhibitor utility","[{\"question\":\"What is SVC112 and what does it target in translation?\",\"answer\":\"SVC112 is a small-molecule inhibitor of translation elongation. It disrupts elongation processes and leads to cancer-cell growth inhibition.\"},{\"question\":\"How does SVC112 act beyond radiation treatment?\",\"answer\":\"SVC112 shows activity on its own without radiation. It suppresses growth across cancer cell lines with a large (1600-fold) range in sensitivity.\"},{\"question\":\"Which molecular signals correlate with SVC112 sensitivity in different cancers?\",\"answer\":\"In hematologic cancer cell lines, basal apoptosis/survival factor expression correlates with SVC112-induced apoptosis. In colorectal cancer cell lines, phosphorylation of c-Myc correlates with sensitivity.\"}]","Sensitivity to an Inhibitor of Translation Elongation in Solid and Hematologic Cancers | PDF",1790171700,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26f102eeac7986768f4b7f9bf731be8f.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c573abadcf4ea0fa03191dee46fc0b7.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/020b9b506af022c01d22753754af45fa.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60893ddb7ca17598de7d1df62e950200.webp",980,1287]